Halozyme Appoints Barbara Duncan to its Board of Directors

Go back to Halozyme Appoints Barbara Duncan to its Board of Directors
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 80.37 --0 (-0%)
Previous Close $80.37    52 Week High $18.39 
Open $80.37    52 Week Low $6.96 
Day High $80.37    P/E N/A 
Day Low $80.37    EPS $-0.58 
Volume 90